Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 15,769 | 13,291 | 11,948 | 10,914 | 10,504 |
| Operating Income | -15,769 | -13,291 | -11,948 | -10,914 | -10,504 |
| Interest Expense | 1 | 1 | 2 | 1 | 2 |
| Other Income | -65 | 2,616 | -86 | 158 | -1,558 |
| Pre-tax Income | -15,835 | -10,676 | -12,036 | -10,757 | -12,064 |
| Income Tax | 50 | N/A | N/A | N/A | -172 |
| Net Income Continuous | -15,885 | -10,676 | -12,036 | -10,757 | -11,892 |
| Net Income | $-15,885 | $-10,676 | $-12,036 | $-10,757 | $-11,892 |
| EPS Basic Total Ops | -0.68 | 3.40 | -0.60 | -0.62 | -5.11 |
| EPS Basic Continuous Ops | -0.68 | 3.07 | -0.60 | -0.61 | -4.79 |
| EPS Diluted Total Ops | -0.68 | 3.40 | -0.60 | -0.62 | -5.11 |
| EPS Diluted Continuous Ops | -0.68 | 3.07 | -0.60 | -0.61 | -4.79 |
| EBITDA(a) | $-15,689 | $-13,216 | $-11,876 | $-10,846 | $-10,441 |